Updated Mar. 22, 2012 at 4:59 p.m.

Premium Lock Pozen shares surge on aspirin therapy trial news

Published: 2012-03-22 07:56:00
Updated: 2012-03-22 16:59:23

Diagram from Pozen presentation about PA technology Diagram from Pozen presentation about PA technology Image 1 of 2 · Next Image…

The Chapel Hill-based pharmaceutical firm says its compound redcues gastric ulcers in two Phase 3 trials of patients who are taking aspirin daily. Pozen plans a new drug application in the third quarter. PLUS: Two board memebers leaving....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll